Wednesday, 08 April 2020

China News

  • 3SBio retains Gottlieb Steen & Hamilton as legal counsel

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2012

    Singapore: 3SBio, a leading China-based biotechnology company focused on R&D, manufacturing and marketing biopharmaceutical products, announced that the special committee of independen...Read more

  • Mr Steven Kaufman, SHL Group: 2013 will be an exciting year for drug delivery devices

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Dec, 2012

    Pharmaceutical companies in the region are starting to take more interest in biologics and biosimilars, and of course with that, we see more interest in devices such as auto injectors. We s...Read more

  • China Cord Blood revenues up 57% to $24.0 mn

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

    Singapore: China Cord Blood, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, revealed its prelimin...Read more

  • Sanjiu Medical keeps focus on R&D

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medical instruments. The company also operates in pharmaceutical trading a...Read more

  • GSK executives confessed to bribery charges: China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's security ministry has said that those involved have confessed to 'serio...Read more

  • J&J puts all Chinese units under single local chairman

    China |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Singapore: The business heads of Johnson & Johnson's (J&J) three Chinese operations would report to one local chairman from next month. This move has been made by the firm in an eff...Read more

  • China develops revolutionary TCM migraine medication

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

    Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine tablet, which demonstrated an effective rate of 96.5 percent in clinica...Read more

  • Can-Fite APIs to be manufactured by China CRO

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2013

    Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF102 are up-scaled and manufactured by Chemspec, a leading Chinese CRO....Read more

  • X-Change to launch Phytiva in China, SE Asia

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jan, 2013

    Singapore: X-Change, a US-based boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, has been in discussions with ...Read more

  • OrbusNeich launches dual therapy heart stent

    China |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2013

    Singapore: Hong Kong-based OrbusNeich has launched dual therapy stent to address the challenges of delayed healing of the coronary artery associated with monotherapy drug eluting stents (DE...Read more

  • China vitamin C manufacturer fined by US court

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Mar, 2013

    Singapore: A US court has fined North China Pharmaceutical (NCPC), a vitamin C manufacturer and antibiotics supplier, $162 million for price fixing. This is the first time that a Chinese dr...Read more

  • Daewoong buys China's Liaoning Baifeng for $20 mn

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Daewoong Pharmaceutical is going to acquire Liaoning Baifeng, a Shenyang (Liaoning Province)-based manufacturer of drug materials, and invest up to $20 million (18 billion won) t...Read more

  • Charles River grows $286 mn in Q1 2013

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 02 May, 2013

    Singapore: Charles River Laboratories has reported an increase of 1.8 percent in first quarter of 2013, clocking $286.0 million as compared to 2012. For the quarter, net sales from continui...Read more

  • Shenzhen Accord all set to go beyond China

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

    China is undergoing healthcare reforms and, in the process, industry regulations are becoming strict. Adopting a new business strategy to lead in the changing business environment, Shenzhen...Read more

  • India, China top 2013's GMP failures: EMA

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2014

    Singapore: In a bid to bring about transparency, the European Medicines Agency (EMA) has released the public version of the EudraGMDP database to put together the statements of non-complian...Read more

  • Dehaier reports decrease in revenue in Q3'12

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, reported a decrease in rev...Read more

  • MedImmune, WuXi form joint venture

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a research and development outsourcing company, have formed a joint venture to develop and commercialize MEDI...Read more

  • HUYA, Sanzao Park partner for drug development

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partnership with Zhuhai Sanzao Science and Technology Industrial Park. The ...Read more